Krka, d. d., Novo mesto

15 March 2010 11:54

You are here: Home

Search
Expand view
Printer Friendly

Krka operations in 2009


Krka Company had sold products worth EUR 850.1 million, which is 3% more than in 2008. The net profit of the Krka Company (based on the preliminary unaudited statements), taking into account the reversal of provisions and the formation of new provisions, will be over EUR 170 million, which is 6% more than in 2008. More

Investors		Press room
	Unaudited financial statements for 2009 January – September 2009 interim report Share trading		Last press release Releases - archive News - archive

For Professionals		OTC Products
	Krka's Generics Prescription pharmaceuticals		Products by disease or condition Products list

KRKG Stock Quote

Quote	Chg.%
64.41	-.54

Local time
2010-3-15, 11:53

Supported by www.mojdenar.com

Share split

News

Elicea^® - New Krka’s antidepressant
Krka offers a wide range of modern medicines for treating depression. The already established antidepressants include...

Krka at 15^th Russian meeting of cardiovascular surgeons
The 15^th Russian meeting of cardiovascular surgeons took place between 6^th and 9^th December 2009 at...

Krka operations in 2009
At a press conference, on 21st January 2010, the Krka Management Board presented sales results for the...

top of page – legal info – privacy policy

Krka, tovarna zdravil, d. d., Novo mesto, Šmarješka cesta 6, SI-8501 Novo mesto, phone: +386 7 331 21 11, telefax: +386 7 332 15 37, e-mail
Krka, d. d., Novo mesto is committed to maintaining the privacy of the personal information of all the visitors to this web site in accordance with the Personal Data Protection Act (Official Gazette of the RS No. 86/2004) and all regulations related to this act.
© 2000 - 2010 — about this site